Analyst Ratings for Atea Pharmaceuticals (AVIR) [Sells]
Avg. $ Target:
N/A
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/10/2023 | JPMorgan | Eric Joseph | Downgrade | Underweight (Neutral) |
N/A (N/A) |
3.41 (3.72) |
9.09% | Details |
| 1/6/2022 | Morgan Stanley | Matthew Harrison | Downgrade | Underweight (Equalweight) |
7.00 (N/A) |
8.30 (3.72) |
-55.18% | Details |
